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Renal tubulointerstitial fibrosis is the common final pathway leading to end-stage renal failure. Tubulointerstitial fibrosis is characterized
by fibroblast proliferation and excessive matrix accumulation. Transforming growth factor-h1 (TGF-h1) has been implicated in the
development of renal fibrosis accompanied by a-smooth muscle actin (a-SMA) expression in renal fibroblasts. To investigate the molecular
and cellular mechanisms involved in tubulointerstitial fibrosis, we examined the effect of TGF-h1 on collagen type I (collagen) gel
contraction, an in vitro model of scar collagen remodeling. TGF-h1 enhanced collagen gel contraction by human renal fibroblasts in a dose-
and time-dependent manner. Function-blocking anti-a1 or anti-a2 integrin subunit antibodies significantly suppressed TGF-h1-stimulated
collagen gel contraction. Scanning electron microscopy showed that TGF-h1 enhanced the formation of the collagen fibrils by cell
attachment to collagen via a1h1 and a2h1 integrins. Flow cytometry and cell adhesion analyses revealed that the stimulation of renal
fibroblasts with TGF-h1 enhanced cell adhesion to collagen via the increased expression of a1 and a2 integrin subunits within collagen gels.
Fibroblast migration to collagen was not up-regulated by TGF-h1. Furthermore, TGF-h1 increased the expression of a putative contractile
protein, a-SMA, by human renal fibroblasts in collagen gels. These results suggest that TGF-h1 stimulates fibroblast–collagen matrix
remodeling by increasing both integrin-mediated cell attachment to collagen and a-SMA expression, thereby contributing to pathological
tubulointerstitial collagen matrix reorganization in renal fibrosis.
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1. Introduction [5–7]. For example, TGF-h1 increases the synthesis andRenal tubulointerstitial fibrosis causes the progressive
renal dysfunction that leads to end-stage renal failure in
renal diseases. Tubulointerstitial fibrosis is characterized by
renal fibroblast proliferation and excessive matrix accumu-
lation in the renal tubulointerstitial compartment following
renal injury [1–4]. Transforming growth factor-h1 (TGF-
h1) is a prime fibrogenic cytokine in renal interstitial
fibrosis [1,2,4]. The fibrogenic potential of TGF-h1 in
renal fibrosis has been reported by several investigators0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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protein including collagens and fibronectin in renal fibro-
blasts, and may thereby stimulate the renal interstitial
deposition of ECM [5,6]. In addition, mice expressing
the TGF-h1 transgene in the liver under the control of
the murine albumin promoter developed glomerulosclerosis
and tubulointerstitial fibrosis [7]. Interestingly, the subcu-
taneous administration of TGF-h1 to rats results in the
formation of a granulation tissue which contains a large
number of fibroblasts that are positive for a-smooth muscle
actin (a-SMA), a myofibroblastic marker [8]. a-SMA-
positive fibroblasts have been implicated in the renal
interstitial fibrosis, renal dysfunction, and prognosis in
IgA nephropathy [9]. These evidences suggest that TGF-
 Fig. 2. Effect of anti-a1 mAb or anti-a2 mAb on collagen gel contraction
by TGF-h1-treated human renal fibroblasts. The degree of TGF-h1 (1 or 10
ng/ml)-treated or untreated (Vehicle) gel contraction by human renal
fibroblasts in the presence of anti-a1 mAb (20 Ag/ml) (a1), anti-a2 mAb
(20 Ag/ml) (a2), or both anti-a1 mAb (20 Ag/ml) and anti-a2 mAb (20 Ag/
ml) (a1 +a2) was compared to that in the presence of control mouse IgG1
(C) at 48 h. The results represent the meanF S.D. (*P < 0.01, **P < 0.05
versus control). N.S. = not significant.
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blasts into myofibroblasts, which are involved in wound
healing and pathological fibrocontractive diseases. Howev-
er, there have been no previous studies of how TGF-h1
affects the ability of renal fibroblasts with respect to the
organization of ECM protein, particularly collagen type I
(collagen), a major ECM protein component in renal
interstitial fibrosis.
The integrins are a large family of heterodimeric cell
adhesion receptors involved in cell–cell and cell–matrix
interactions [10]. They are composed of noncovalently
linked a and h subunits. The integrins include all of the
known cellular receptors for collagen matrix, i.e., a1h1,
a2h1, a3h1, a10h1, a11h1 heterodimers [11]. Two of the
best known collagen receptors are a1h1 and a2h1. a1h1
integrin is abundant on smooth muscle cells and glomerular
mesangial cells, whereas a2h1 integrin is the major colla-
gen receptor on epithelial cells and platelets. Many cell
types, such as fibroblasts, osteoblasts, chondrocytes, endo-
thelial cells, and lymphocytes concomitantly express both
receptors [11]. These integrin receptors modulate critical
cellular processes, including adhesion, migration, survival,
ECM organization, and differentiation. These processes are
physiologically related to growth, development, and tissue
homeostasis, but may also be significant in pathological
conditions such as renal fibrosis [12]. In fact, Roy-Chaud-Fig. 1. Effect of TGF-h1 on collagen gel contraction by human renal
fibroblasts. (A) Human renal fibroblasts cultured in collagen gels were
treated with TGF-h1 (1 or 10 ng/ml) for 48 h. The degree of gel contraction
by TGF-h1-treated cells was compared with that by untreated cells
(Control) at 24 and 48 h. There was a significant difference between control
and 10 ng/ml at 24 h. There was also a significant difference between
control and 1 ng/ml, or 1 and 10 ng/ml at 48 h. The results represent the
meanF S.D. (*P < 0.01). (B) The representative photomicrographs of
collagen gels at 48 h.hury et al. [13] reported that the expression of a1h1 and
a2h1 integrins is up-regulated in human renal interstitial
fibrosis.
We hypothesized that both a1h1 and a2h1 integrins
might play an important role in TGF-h1-induced patho-
logical ECM organization by renal fibroblasts. To inves-
tigate the molecular mechanisms involved in the abnormal
collagen matrix organization by renal fibroblasts, we
examined the effect of TGF-h1 on collagen gel contrac-
tion, an in vitro model of collagen matrix remodeling and
scar formation. The present study showed that TGF-h1
stimulates collagen gel contraction via an increase in
a1h1 and a2h1 integrin-mediated cell attachment to
collagen. In addition, TGF-h1 may synergistically enhance
gel contraction through the increased expression of a-
SMA by renal fibroblasts.Table 1







Vehicle 83.3F 4.2 85.3F 2.1N.S. 95.8F 1.0a 99.7F 0.6a
TGF-h1
(1 ng/ml)
70.8F 1.2b 75.1F 2.1c 90.4F 6.2a 97.6F 2.1a
TGF-h1
(10 ng/ml)
47.5F 2.2d 70.9F 4.7a 80.8F 1.7a 97.5F 2.2a
Vehicle, in the absence of TGF-h1: Control, control antibodies (mouse
IgG1). The results represent the meanF S.D. N.S. = not significant.
a P< 0.01.
b P < 0.01 versus vehicle.
c P< 0.05 versus control.
d P < 0.01 versus TGF-h1 (1 ng/ml).
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2.1. Antibodies and reagents
Monoclonal anti-human a1 integrin subunit antibody
(FB12) (anti-a1 mAb) and anti-human a2 integrin subunit
antibody (P1E6) (anti-a2 mAb) were purchased from Chem-
icon Int. (Temecula, CA). These antibodies have been shown
to block integrin adhesive function in several studies using
human skin and renal fibroblasts [14–17]. They were
applied at the same protein concentration (20 Ag/ml) as
function-blocking antibodies [14–16]. Polyclonal rabbit
anti-h1 integrin subunit antibody (anti-h1 Ab) was a kind
gift from Drs. K. Lo¨ster and W. Reutter (Freie Universitat
Berlin, Germany). Mouse myeloma IgG1 (mIgG1) (Zymed
Laboratories Inc., San Francisco, CA) and normal rabbit IgGFig. 3. Effect of anti-a1 mAb and anti-a2 mAb on the formation of collagen fib
formation of collagen fibrils in collagen gels for 48 h were examined by scan
fibroblasts treated with TGF-h1(10 ng/ml). TGF-h1 increased the number of pr
representative formation of condensed and packed collagen fibrils in collagen gels
a1 and a2 mAbs (20 Ag/ml). Anti-a1 and a2 mAbs suppressed TGF-h1-induced
packed collagen fibrils.  42,000. Bars = 2 Am.(Rab IgG) (Zymed Laboratories Inc.) were used as control
antibodies for all experiments. Fluorescein isothiocyanate
(FITC)-conjugated donkey polyclonal antibody against ei-
ther mouse or rabbit IgG was purchased from Jackson
ImmunoResearch Laboratories Inc. (West Grove, PA). An-
ti-a-SMA monoclonal antibody (1A4) and anti-h-actin
monoclonal antibody (AC-15) were purchased from Sigma
Chemical Co. (St. Louis, MO). Horseradish peroxidase
(HRP)-conjugated rabbit anti-mouse IgG (New England
Biolabs, Beverly, MA) was used for Western blot analysis.
2.2. Cells and culture
Human renal interstitial fibroblast cell line (Tk188) has
been established and characterized as previously described
[18,19]. This cell line was obtained from the medullary partrils by TGF-h1-treated human renal fibroblasts. Renal fibroblasts and the
ning electron microscopy. (A) Control experiments.  42,000. (B) Renal
ickles or collagen fibrils anchored to the cell surface.  42,000. (C) The
.  96,000. (D) Renal fibroblasts treated with TGF-h1 (10 ng/ml) and anti-
prickles on the cell surface and abolished the formation of condensed and
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interstitial fibrosis. The use of the cells was approved by
the local ethics committee and informed consent was
obtained from the patient. All experiments were performed
after incubation for 24 h in serum-free RPMI 1640 (Gibco
BRL, Grand Island, NY) to achieve fibroblast quiescence.
2.3. Collagen gel contraction assay
Collagen gel contraction assays were performed to ex-
amine the ability of human renal fibroblasts to reorganize
and contract three-dimensional collagen gels [20]. QuiescentFig. 4. Effect of TGF-h1 on the expression of a1, a2, and h1 integrins by huma
expression by flow cytometry analyses. After collagen gel-cultured fibroblasts wer
isolated and subjected to flow cytometry analysis with either anti-a1 mAb, anti-a
appropriately replaced with mouse IgG1 (mIgG1) or normal rabbit IgG (Rab IgG
histogram. The MFI of mIgG1 and Rab IgG were 0.528 and 1.13, respectively. (
(*P< 0.01, **P < 0.05). (a1) a1 integrin subunit. (a2) a2 integrin subunit. (h1)fibroblasts were harvested and suspended in the absence or
presence of anti-a1 mAb or anti-a2 mAb at a concentration
of 4 10 5 cells/ml, mixed with collagen solution [59%
1.25 RPMI 1640, 40% rat tail collagen (3.75 mg/ml), 1%
0.2N NaOH]. Final collagen concentration is 0.75 mg/ml.
Collagen/cell suspensions were incubated in 12-, 24- (Co-
star, Cambridge, MA), or 96- (Becton-Dickinson Labware,
Lincoln Park, NJ) well plates at 37 jC for 1 h to polymerize
the collagen, and the gels were then gently cut away from the
sides of the well and lifted off the bottom by adding serum-
free RPMI 1640. The diameter of the hydrated gels was
measured using an inverted microscope at 24 and 48 h. TGF-n renal fibroblasts in collagen gels. (A) The representative data of integrin
e treated with or without TGF-h1 (1 or 10 ng/ml) for 48 h, fibroblasts were
2 mAb, or anti-h1 Ab. For background staining, the primary antibody was
) (dotted lines). The mean fluorescence intensity (MFI) is shown under the
B) The results were shown as meanF S.D. by analyzing MFI of integrins.
h1 integrin subunit.
Fig. 5. Effect of TGF-h1 on migration to collagen. Human renal fibroblasts
were added to the upper chamber of a transwell apparatus containing a
membrane coated on the lower side with 20 Ag/ml collagen. The lower
chamber was supplemented with or without TGF-h1 (1 or 10 ng/ml). Cells
that penetrated to the lower chamber were quantified over 6 h. Results
represent the meanF S.D. of migrated cells in 10 high-power fields.
N.S. = not significant.
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before gel polymerization and when the gels were lifted.
2.4. Scanning electron microscopy
Renal fibroblasts cultured in collagen gels for 48 h were
fixed with 2.5% glutaraldehyde in 0.1 M phosphate-buffered
saline (PBS), pH 7.4. The fixed specimens were rinsed with
the same buffer for 15 min and postfixed with 1% osmium
tetroxide for 1 h. After dehydration by passage through a
graded ethanol series, the specimens were infiltrated with
tert-butyl alcohol. These specimens were dried by critical
point dry methods, and coated with gold and paradium by an
ion coating device (S-800, Hitachi, Japan). The specimens
were then examined with scanning electron microscope
(E5150, Polaron Equipment Lim., Watford, UK) [21].
2.5. Flow cytometry analyses
Flow cytometry analyses were performed to examine the
cell surface expression of the a1, a2, and h1 integrin
subunits in human renal fibroblasts cultured on plastic or
in collagen gels [22]. Isolated fibroblasts from either culture
plates (Nunc Inc., Naperville, IL) with 0.05% trypsin and
0.02% EDTA, or digested collagen gels with 1 mg/ml
collagenase type II (Sigma) were incubated with either
anti-a1 mAb, anti-a2 mAb, or anti-h1 Ab, washed, and
resuspended in the appropriate FITC-conjugated secondary
antibodies. Regarding the artificial effect of collagenase on
cell surface integrin expression during the isolation of cells
from collagen gels, we confirmed that collagenase did not
affect surface integrin expression by renal fibroblasts cul-
tured on collagen-coated plates. Stained cells were analyzed
for fluorescence on a FACStar Plus Flow Cytometer (Bec-
ton-Dickinson). For background staining, the primary anti-
body was replaced with mIgG1 or Rab IgG. Ten thousand
cells were separately analyzed for FITC fluorescence to
quantitate the amount of bound antibodies per cell. The
fluorescence intensities of these cells were averaged. The
arithmetic mean thus calculated is called the mean fluores-
cence intensity (MFI) [23]. Expression of integrin was
shown as meanF S.D. by analyzing MFI in three separate
experiments (*P < 0.01, **P < 0.05).
2.6. Migration assay
Transwell chambers (6.5 mm; Costar) with an 8-Am pore
membrane were used to assess the migratory activity of
renal fibroblasts [24]. The underside of the membrane was
coated overnight at 4 jC with 20 Ag/ml collagen. Control
wells contained no collagen. The lower chamber was rinsed
twice with RPMI 1640–0.1% bovine serum albumin (BSA).
Growth-arrested renal fibroblasts were detached, washed,
and suspended in RPMI 1640–0.1% BSA. Cells were added
to the upper chamber of the transwell at 5 10 5 cells/well.
The indicated amount of TGF-h1 was included in the lowerchamber. After 6 h of incubation, renal fibroblasts on the
upper surface were removed by scraping so that only cells
that had migrated through the membrane remained. The
membrane was fixed with methanol, stained with Diff-Quik
(Baxter, McGaw Park, IL), and excised from the plastic
supports and allowed to air-dry on a glass slide with
Permount (Sigma). Cells were counted at  400 magnifi-
cation in 10 microscope fields per filter. Background cell
numbers due to migration to wells containing no collagen
were subtracted from the values that reflected collagen-
dependent migration. Assays were performed in triplicate
and values presented are the means F S.D. of 30 fields
from three filters.
2.7. Cell adhesion assay
Flat bottom plates (96-well) were coated overnight at 4
jC with collagen I (10 Ag/ml) and then blocked with 10 mg/
ml BSA for 1 h at 37 jC. Quiescent fibroblasts were
pretreated with or without TGF-h1 for 48 h, and then
detached, washed, and pelleted. Cells were suspended in
RPMI 1640 containing 1 mM MgCl2 and 1 mM CaCl2, and
then preincubated with anti-a1 mAb, anti-a2 mAb, or
mIgG1 for 30 min at 37 jC, plated onto collagen-coated
wells at 5 10 4 cells/well, and incubated at 37 jC for 50 min
in the presence of anti-a1 mAb, anti-a2 mAb, or mIgG1.
Cell adhesion was evaluated by staining adherent cells with
0.1% crystal violet, solubilizing cells with 0.2% Triton X-
100 in PBS, and reading the absorbance at 630 nm with a
Corona Microplate Reader (Corona Electric Co., Ibaragi,
Japan). This quantification procedure was demonstrated to
give values proportional to the number of adherent cells.
Fig. 6. (A) Effect of anti-a1 mAb or anti-a2 mAb on TGF-h1-treated fibroblast adhesion to collagen. Human renal fibroblasts were treated with TGF-h1 (1 or
10 ng/ml) or vehicle (Control) for 24 h, and then detached and preincubated with either anti-a1 mAb (20 Ag/ml) (anti-a1) or anti-a2 mAb (20 Ag/ml) (anti-a2)
before they were added to collagen-coated wells. The degree of cell adhesion by human renal fibroblasts in the presence of anti-a1 mAb or anti-a2 mAb (20
Ag/ml) was compared to that in the presence of appropriate control antibodies (mouse IgG1 (mIgG1)) at 48 h (*P < 0.01). (B) Effect of TGF-h1 on the
expression of a1, a2, and h1 integrins by human renal fibroblasts on plastic. The representative data of integrin expression by flow cytometry analyses. After
collagen gel-cultured fibroblasts were treated with or without TGF-h1 (10 ng/ml) for 48 h, fibroblasts were isolated and subjected to flow cytometry analysis
with either anti-a1 mAb, anti-a2 mAb, or anti-h1 Ab. For background staining, the primary antibody was appropriately replaced with mouse IgG1 (mIgG1) or
normal rabbit IgG (Rab IgG) (dotted lines). The mean fluorescence intensity (MFI) is shown under the histogram. The MFI of mIgG1 and Rab IgG were 0.412
and 0.301, respectively. (C) The results were shown as meanF S.D. by analyzing MFI of integrins. (*P< 0.01). (a1) a1 integrin subunit. (a2) a2 integrin
subunit. (h1) h1 integrin subunit.
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Bioph2.8. Western blot analyses
Western blot analyses were performed as described
previously [25]. Isolated fibroblasts from digested collagen
gels were then lysed for 30 min on ice in a lysis buffer
(Cell Signaling Technology, Inc., Beverly, MA). Protein
samples (25 Ag) were separated by 12.5% SDS-PAGE and
transferred to nitrocellulose membranes. The membranes
were probed with an anti-a-SMA monoclonal antibody,
and then incubated with an HRP-conjugated rabbit anti-
mouse IgG. Immunoreactive proteins were detected with
an enhanced chemiluminescence detection system (Amer-
sham Corp., Arlington Heights, IL). Blots were stripped
and probed with an anti-h-actin monoclonal antibody to
confirm equal loading and transfer. Bands were quantitated
by densitometric scanning using an LKB UltroScan
XL apparatus (Pharmacia LKB Biotechnology, Uppsala,
Sweden).
2.9. Statistical analyses
Results are presented as meanF S.D. A value of P < 0.05
was used to determine statistical significance (t-test). Trip-
licate wells were analyzed for each experiment, and each
experiment was performed independently a minimum of
three times.
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Summary of the data shown in Fig. 6A
mIgG1 anti-a1 mAb anti-a2 mAb
Control 0.236F 0.011 0.119F 0.006a 0.149F 0.016a
TGF-h1 (1 ng/ml) 0.387F 0.010b 0.215F 0.020a 0.264F 0.017a
TGF-h1 (10 ng/ml) 0.446F 0.017c 0.291F 0.022a 0.369F 0.023a
mIgG1, control antibodies (mouse IgG1). The results represent the
meanF S.D.
a P < 0.01 versus mIgG1.
b P< 0.01 versus control.
c P < 0.01 versus TGF-h1 (1 ng/ml).3. Results
3.1. a1b1 and a2b1 integrins mediate TGF-b1-induced
collagen gel contraction by renal fibroblasts
First, we investigated whether TGF-h1 stimulates col-
lagen matrix reorganization by renal fibroblasts using a
collagen gel contraction system. As shown in Fig. 1, TGF-
h1 enhanced collagen gel contraction in a dose- and time-
dependent manner (P < 0.01, respectively). Since human
renal fibroblasts express collagen-binding a1h1 and a2h1
integrins in the renal interstitium [13,15], we next exam-
ined the involvement of a1h1 and a2h1 integrins in TGF-
h1-enhanced collagen gel contraction with function-block-
ing anti-a1 mAb and anti-a2 mAb. As shown in Fig. 2
and Table 1, collagen gel contraction was not inhibited by
anti-a1 mAb under control conditions. Collagen gel con-
traction was suppressed by anti-a2 mAb and the combi-
nation of anti-a1 mAb and anti-a2 mAb, respectively.
This suggests that collagen gel contraction is mainly
mediated by a2h1 integrin under control conditions.
However, TGF-h1-induced gel contraction was significant-
ly suppressed by incubation with either anti-a1 mAb or
anti-a2 mAb. The simultaneous addition of both anti-
bodies completely inhibited collagen gel contraction.
These results indicated that both integrins mediated
TGF-h1-induced collagen matrix reorganization by renal
fibroblasts.3.2. TGF-b1 enhances the formation of condensed collagen
fibrils by cell attachment to collagen via a1b1 and a2b1
integrins
Scanning electron microscopy revealed that TGF-h1
increased the number of prickles, which might correspond
to putative interacting sites with collagen fibrils, on the cell
surface, and enhanced the formation of condensed and
packed collagen fibrils anchored to the cell surface as
compared with control experiments (Fig. 3A and B). Fig.
3C shows the representative collagen bundles enhanced by
TGF-h1. In addition, incubation with either anti-a1 mAb or
anti-a2 mAb suppressed TGF-h1-induced prickles on the
cell surface. Particularly, co-incubation with both antibodies
abolished TGF-h1-induced prickles and formation of con-
densed and packed collagen fibrils (Fig. 3D).
3.3. TGF-b1 stimulates the expression of a1b1 and a2b1
integrins by renal fibroblasts within collagen gels
Previous investigations have shown that TGF-h1 en-
hanced the expression of h1 integrins on many types of
cells, such as human osteosarcoma cells and rat mesangial
cells [26,27]. However, there have been no reports on
whether TGF-h1 affects the expression of a1h1 and a2h1
integrins by human renal fibroblasts within collagen gels. To
examine how renal fibroblasts express a1 and a2 integrin
subunits, we investigated the expression of a1, a2, and h1
integrin subunits by flow cytometry. a2 and h1 integrin
subunits were strongly expressed, while a1 integrin subunit
was weakly expressed on human renal fibroblasts in colla-
gen gels. TGF-h1 (1 or 10 ng/ml) significantly enhanced the
expression of a1, a2, and h1 integrin subunits in a dose-
dependent manner (P < 0.05) (Fig. 4A and B).
3.4. TGF-b1 enhances cell adhesion, but not migration to
collagen by renal fibroblasts
Cell attachment to collagen fibers and cell migration
within collagen gels are critical components of collagen
matrix remodeling. Therefore, we examined whether TGF-
h1 could influence fibroblast adhesion and/or migration
using cell adhesion and migration assays, respectively.
Compared with control fibroblast migration, TGF-h1 (1 or
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suggesting that migration activity is not directly involved in
TGF-h1-induced gel contraction (Fig. 5). In contrast, the
cell adhesion assay showed that TGF-h1 stimulated renal
fibroblast adhesion to collagen in a dose-dependent manner
(1 or 10 ng/ml) (Fig. 6A, Table 2). In parallel to the
increased adhesion to collagen, flow cytometry revealed
that TGF-h1 (10 ng/ml) significantly enhanced the expres-
sion of a1, a2, and h1 integrin subunits by renal fibroblasts
cultured on plastic under the same conditions (P < 0.01)
(Fig. 6B and C). Integrin-function-blocking experiments
showed that TGF-h1-induced fibroblast adhesion to colla-
gen is significantly suppressed by incubation with either
anti-a1 mAb or anti-a2 mAb, indicating that TGF-h1-
stimulated fibroblast adhesion to collagen is mediated by
the increased expression of a1h1 and a2h1 integrins on
renal fibroblasts (Fig. 6A, Table 2). Blocking of either a1h1
or a2h1 integrin could not completely abolish cell adhesion
to collagen under TGF-h1-stimulation, suggesting that other
adhesive receptors may partially play a role in cell adhesion
under TGF-h1 stimulation. Collectively, these results sug-
gest that TGF-h1 stimulates collagen gel contraction
through increased a1h1 and a2h1 integrin-mediated cell
attachment within collagen gels.Fig. 7. Expression of a-SMA by human renal fibroblasts in collagen gels.
The renal fibroblasts were incubated with TGF-h1 for 48 h. Total protein
was extracted from the cultured fibroblasts. (A) The samples were adjusted
to a standard content (25 Ag) and analyzed by Western blotting using the
anti-a-SMA monoclonal antibody. Blots were stripped and probed with an
anti-h-actin monoclonal antibody to confirm equal loading and transfer. (B)
The findings of densitometric analysis are analysed and the results represent
the meanF S.D. (*P< 0.01 versus control).3.5. TGF-b1 stimulates the expression of a-SMA by renal
fibroblasts within collagen gels
The expression of a-SMA was enhanced in the area of
renal interstitial fibrosis in human diseased kidney [9]. TGF-
h1 has been implicated in the activation of myofibroblasts
with enhanced a-SMA expression in vivo and in vitro [8].
To clarify whether a-SMA expression is associated with
TGF-h1-stimulated collagen reorganization by renal fibro-
blasts, the expression level of renal fibroblast a-SMA in
collagen gels was investigated by Western blotting. TGF-h1
induced 1.3-fold and 2.1-fold increases at 1 and 10 ng/ml,
respectively, indicating that TGF-h1 induces a-SMA pro-
tein by renal fibroblasts in collagen gels (Fig. 7).
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To the best of our knowledge, this is the first demon-
stration that TGF-h1 stimulates collagen matrix remodeling
by renal fibroblasts. TGF-h1 increased the potential for
fibroblasts to adhere to collagen via the increased expression
of a1h1 and a2h1 integrins on the cell surface. Addition-
ally, TGF-h1 enhanced the expression of a putative con-
tractile protein, a-SMA, by fibroblasts within collagen gels,
suggesting that TGF-h1 might influence intracellular ten-
sion leading to cell construction through myofibroblast
differentiation. The three-dimensional collagen gel culture
system used here has been considered to be an in vitro assay
model of collagen matrix remodeling, similar to wound
healing, fibrosis, and contraction scarring [28]. In this
system, collagen fibers are reconstituted into thick bundles
via adhesion and migration toward collagen fibers, and cell
contraction during the course of gel contraction [24,25,28].
These cell behaviors appear to be essential for the fibroblast-
induced irreversible, massive collagen bundle formation
observed in progressive interstitial fibrosis. Considerable
evidence indicates that TGF-h1 is a representative fibrogenic
factor for the development of pathological interstitial ECM
remodeling following renal injury [4,29,30]. Therefore, our
present results suggest that the effects of TGF-h1 on
integrin and a-SMA expression in renal fibroblasts are
involved in TGF-h1-induced interstitial collagen matrix
reorganization in diseased kidney. Recently, Roy-Chaud-
hury et al. [13] reported that the expression of the a1 and a2
integrin subunits was increased within the area of interstitial
fibrosis in human renal diseases. Many cell culture studies
using various cell types such as human osteogenic cells, skin
and gingiva fibroblasts have demonstrated that a2h1 integ-
rin is a critical collagen receptor for collagen gel contrac-
tion, and TGF-h1 enhanced gel contraction by increasing
a2h1 integrin expression [16,26,31,32]. Similarly, Kely-
nack et al. [15] showed that collagen fibril rearrangement
by human renal fibroblasts in vitro appears to be an integrin-
mediated process involving the a2h1 integrin. However, we
found here that human renal fibroblasts expressed a1 and
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although expression level of a2 integrin subunit is high,
while that of a1 integrin subunit is relative low. Of note,
preincubation with anti-a1 mAb suppressed TGF-h1-in-
duced gel contraction but not untreated gel contraction,
suggesting that a1 integrin subunit may be an important
molecule in TGF-h1-induced pathological settings such as
renal interstitial fibrosis. Similarly, we have shown that
a1h1 integrin is a major collagen receptor expressed on
mesangial cells (MCs) for abnormal mesangial ECM remod-
eling in diseased glomeruli [33]. TGF-h1 stimulated a1h1
integrin-mediated MC adhesion but not migration to colla-
gen, and thereby enhanced collagen gel contraction. Taken
together, these parallel TGF-h1 action on ECM remodeling
by MC and renal fibroblast may play a major role in ECM
remodeling involved in the progression of kidney diseases.
The difference in the expression of collagen-binding integ-
rin subunits in human renal fibroblasts and mesangial cells
might reflect the distinct functional roles of these integrins
in fibrotic processes, since it has been reported that a1h1
integrin mediates the signals, including the down-regulation
of collagen gene expression, whereas a2h1 integrin medi-
ates the induction of matrix metalloproteinase-1 [34]. Fur-
ther study is required to clarify the molecular mechanisms
involved in a1h1 and a2h1 integrin-mediated collagen
matrix remodeling by renal fibroblasts.
In addition to being a well-accepted marker for myofi-
broblast differentiation, a-SMA has also been suggested to
play a role in the production of contractile force during
wound healing and fibrocontractile disease [35]. Hinz et al.
[36] showed that the enhancement of collagen gel contrac-
tion by 3T3 fibroblasts transfected with a-SMA cDNA was
accompanied by increased a-SMA expression and cell
contraction compared with nontransfected cells. In the
present study, TGF-h1 induced a-SMA expression by renal
fibroblasts in collagen gels, suggesting that TGF-h1 enhan-
ces collagen gel contraction via increased fibroblast con-
traction. Recent studies also showed that gel contraction by
cardiac fibroblasts is stimulated by TGF-h1 [37]. This
stimulation of gel contraction was accompanied by induc-
tion of a-SMA. Thus, the increase of cell cytoskeleton, such
as a-SMA, as well as enhanced integrin-mediated cell
binding to collagen fibrils might play a role in TGF-h1-
induced collagen matrix reorganization by fibroblasts. In-
terestingly, we previously showed that the overexpression of
a1 integrin subunit in rat mesangial cells is accompanied by
the increased expression of a-SMA and enhanced collagen
gel contraction [24]. Furthermore, several recent studies
have indicated that the a1 integrin subunit plays a major
role in the contractile capacity of several cell lines including
rat cardiac fibroblasts and mesangial cells, suggesting that
there is a close link between a1 integrin and a-SMA
expression [20,22,38,39].
In conclusion, we have demonstrated that TGF-h1 stim-
ulates renal fibroblast – collagen matrix reorganization
through an increase in cell activity regarding integrin-mediated adhesion to collagen and contraction. Considering
that TGF-h1 is a representative fibrogenic factor that
induces renal interstitial fibrosis, the integrin is its down-
stream player for the substantial assembly of interstitial
collagen matrix. Therefore, strategies that target the colla-
gen-binding integrin expressed on renal fibroblasts may
permit the development of new therapeutic methods for
the inhibition of progressive renal fibrosis.Acknowledgements
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